Jieheng Wu
Overview
Explore the profile of Jieheng Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Feng Y, Zhai J, Vollkommer T, Gosau M, Smeets R, Rutkowski R, et al.
In Vivo
. 2025 Feb;
39(2):1134-1147.
PMID: 40010974
Background/aim: Head and neck cancer (HNC) is the sixth most common type of cancer worldwide. While it is widely accepted that human papillomavirus (HPV) infection is a crucial risk factor...
2.
Wu J, Zhang Q, Yang Z, Xu Y, Liu X, Wang X, et al.
J Cell Mol Med
. 2024 Aug;
28(16):e70025.
PMID: 39164826
Metastasis is a crucial stage in tumour progression, and cancer-associated fibroblasts (CAFs) support metastasis through their participation in extracellular matrix (ECM) stiffness. CD248 is a possible biomarker for non-small cell...
3.
Xiao J, Yang Z, Wang S, Liu X, Wang Y, Hu Z, et al.
Sci Rep
. 2024 Jun;
14(1):14343.
PMID: 38906929
Non-small cell lung cancer (NSCLC)-originating cancer-associated fibroblasts (CAFs) expressing CD248 regulate interaction with immune cells to accelerate cancer progression. Epithelial-mesenchymal transition (EMT) is a key feature of metastatic cells. In...
4.
Yang N, Zhang C, Zhang Y, Fan Y, Zhang J, Lin X, et al.
J Transl Med
. 2024 Mar;
22(1):274.
PMID: 38475814
Background: Chimeric antigen receptor natural killer (CAR-NK) cells represent a promising advancement in CAR cell therapy, addressing limitations observed in CAR-T cell therapy. However, our prior study revealed challenges in...
5.
Wu J, Zhang Q, Wu J, Yang Z, Liu X, Lou C, et al.
J Cell Mol Med
. 2024 Feb;
28(4):e18185.
PMID: 38396325
Chemotherapy-resistant non-small cell lung cancer (NSCLC) presents a substantial barrier to effective care. It is still unclear how cancer-associated fibroblasts (CAFs) contribute to NSCLC resistance to chemotherapy. Here, we found...
6.
Wu J, Zhang Q, Yang Z, Zhang R, Zhang J, Zeng Z, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
. 2024 Jan;
40(2):168-173.
PMID: 38284258
Cancer associated fibroblasts (CAFs) are one of the main components of tumor microenvironment (TME). In TME, the interaction between tumor cells and non-tumor cells or among non tumor cells can...
7.
Wu J, Liu X, Wu J, Lou C, Zhang Q, Chen H, et al.
Biochim Biophys Acta Mol Basis Dis
. 2022 Aug;
1868(11):166521.
PMID: 35985448
Nonsmall cell lung cancer (NSCLC) is among the most prevalent malignant tumours threatening human health. In the tumour microenvironment (TME), cancer-associated fibroblasts (CAFs) induce M2-polarized macrophages, which strongly regulate tumour...
8.
Wei F, Jing H, Wei M, Liu L, Wu J, Wang M, et al.
Aging (Albany NY)
. 2020 Dec;
12(24):26199-26220.
PMID: 33346749
Ring finger protein 2 (RNF2) is an important component of polycomb repressive complex 1. RNF2 is upregulated in many kinds of tumors, and elevated RNF2 expression is associated with a...
9.
Li Y, Han D, Wu P, Ren J, Ma S, Zhang J, et al.
Sci Rep
. 2020 Jul;
10(1):10963.
PMID: 32620790
The study was aimed at assessing the diagnostic performance of Ga-PSMA-617 PET/CT in the detection of prostate cancer (PCa) in patients with a prostate-specific antigen (PSA) level of 4-20 ng/ml...
10.
Yang F, Wei Y, Han D, Li Y, Shi S, Jiao D, et al.
Cancer Res
. 2020 Jun;
80(18):3892-3905.
PMID: 32591411
Fibroblasts and macrophages play key roles in the development of hepatocellular carcinoma (HCC). However, cross-talk between these two kinds of cells has not been well studied. Endosialin (CD248/TEM1) is a...